题名 | CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer. |
链接 | http://jco.ascopubs.org/content/33/14/1564.long |
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |